Transcriptome profiling indicating canine parvovirus type 2a as a potential immune activator.

Area of Science:

• Virology
• Immunology
• Cell Biology

Background:

• Canine parvovirus type 2a (CPV-2a) causes severe disease in dogs.
• The mechanisms of CPV-2a's interaction with host cell regulation and immune responses are not fully understood.

Purpose of the Study:

• To investigate the effects of persistent CPV-2a infection on MDCK cells.
• To elucidate the molecular mechanisms underlying CPV-2a-induced host immune activation.

Main Methods:

• Generation of persistently CPV-2a-infected MDCK cell lines through serial passage.
• Polymerase Chain Reaction (PCR) for viral gene detection.
• Immunofluorescence assay for viral particle localization.
• Transcriptome microarray analysis for gene expression profiling.
• Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis.
• Quantitative PCR (qPCR) for gene expression validation.

Main Results:

• CPV-2a infection induced cell proliferation arrest and morphological changes, which normalized after several passages.
• Persistent infection led to distinct gene expression patterns compared to normal cells.
• Upregulated genes were associated with membrane proteins, MHC complexes, and immune signaling pathways (antigen processing, intestinal immunity, RIG-I-like helicases).
• Downregulated genes were primarily involved in amino acid synthesis and metabolism.

Conclusions:

• CPV-2a acts as a natural immune activator, capable of stimulating host immune responses.
• The findings suggest potential applications of CPV-2a in developing novel antiviral strategies and medical biomaterials.